 |
 |
 |
|
Address
|
|
THIRD POINT LLC
|
|
390 PARK AVENUE
|
|
NEW YORK, NY 10022
|
|
(212) 224-7400
|
|
 |
 |
|
Position Statistics
|
|
Report Date:9/30/2009
|
|
Total Value (in $Millions): $1,111
|
|
Turnover (in Millions):
60
|
|
Click on the column header links to resort ascending ( )
or descending ( ).
|
 |
 |
 |
Company
Select a company below for more information.
|
Class
|
Value ($1000)
|
Change ($1000)
|
% Change
|
Shares Held
|
|
PFIZER INC
|
COM
|
$111,401
|
$25,603
|
29.84%
|
6,151,350
|
|
CF INDS HLDGS INC
|
COM
|
$66,296
|
($4,144)
|
(5.88%)
|
800,000
|
|
LIBERTY ACQUISITION HLD...
|
COM
|
$65,614
|
$0
|
0.00%
|
6,914,000
|
|
PHH CORP
|
COM NEW
|
$63,750
|
$0
|
0.00%
|
4,480,000
|
|
HEALTH NET INC
|
COM
|
$59,940
|
$59,940
|
New
|
3,000,000
|
|
BANK OF AMERICA CORPORA...
|
COM
|
$48,240
|
($58,692)
|
(54.89%)
|
3,000,000
|
|
POPULAR INC
|
COM
|
$43,310
|
$43,310
|
New
|
17,750,000
|
|
TRANSDIGM GROUP INC
|
COM
|
$41,780
|
$41,780
|
New
|
1,000,000
|
|
WELLPOINT INC
|
COM
|
$41,712
|
$41,712
|
New
|
800,000
|
|
CABLEVISION SYS CORP
|
CL A NY CABLVS
|
$38,730
|
$38,730
|
New
|
1,500,000
|
|
MOLSON COORS BREWING CO
|
CL B
|
$36,576
|
$11,430
|
45.45%
|
800,000
|
|
NABI BIOPHARMACEUTICALS
|
COM
|
$32,245
|
$0
|
0.00%
|
6,890,000
|
|
APPLE INC
|
COM
|
$30,077
|
$0
|
0.00%
|
150,000
|
|
HEWLETT PACKARD CO
|
COM
|
$29,892
|
$0
|
0.00%
|
600,000
|
|
ALLERGAN INC
|
COM
|
$29,325
|
$0
|
0.00%
|
500,000
|
|
TRIAN ACQUISITION I COR...
|
COM
|
$27,033
|
$0
|
0.00%
|
2,750,000
|
|
LIBERTY MEDIA CORP NEW
|
ENT COM SER A
|
$25,137
|
$0
|
0.00%
|
700,000
|
|
MERCK & CO INC NEW
|
PFD CONV 6%
|
$24,819
|
$0
|
0.00%
|
100,000
|
|
CAREFUSION CORP
|
COM
|
$22,662
|
$22,662
|
New
|
900,000
|
|
DEPOMED INC
|
COM
|
$22,203
|
$0
|
0.00%
|
6,790,000
|
|
 |
|
|
Institutional Ownership supplied by EDGAR Online, Inc. Copyright 2009, EDGAR Online, Inc. All rights reserved. Replication or redistribution expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|
|
|